As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies, possible wider usage and a ...

Recent data reveals a sharp rise in the use of weight loss drugs among U.S. youth, with significant gender disparities and ...

Nearly 60% of Americans who started taking weight-loss drugs between 2014 and 2023 didn’t continue ... The popularity and ...

Use of diabetes and obesity medications such as Ozempic, Wegovy and other so-called GLP-1 drugs has soared among teens and ...

The survey found 6% of Americans say they have tried the drugs for weight reduction, with 3% currently taking the injections.

Share on Pinterest A new study finds the benefits of Wegovy for diabetes, heart disease, and weight loss can last up to four years. Iuliia Burmistrova/Getty Images A new study finds the benefits ...

More than half of people prescribed weight-loss drugs Saxenda and Wegovy over the past decade ended their treatment too early to realize meaningful health benefits, according to a study by a major ...

The study looked at whether people on Wegovy maintained their weight loss. Amid the growing popularity of drugs used for weight loss like Ozempic, Wegovy, Mounjaro and Zepbound, one question has ...

Unsurprisingly, against this backdrop, the launch of weight loss drugs, such as Wegovy, which work by reducing appetite and also cut the risk of a heart attack, has taken the world by storm.

Unsurprisingly, against this backdrop, the launch of weight loss drugs, such as Wegovy, which work by reducing appetite and also cut the risk of a heart attack, has taken the world by storm.

NurPhoto/Getty Images Researchers report that more than half of people on weight loss drugs Wegovy and Saxenda stop taking them at 12 weeks or earlier. They said that 30% of people on the drugs ...

A large, long-term trial of the weight-loss medication Wegovy (semaglutide) found that people tended to lose weight over the first 65 weeks on the drug—about one year and three months—but then ...